rs79928962
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000602285.1(NSD1):n.1147A>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0251 in 1,451,320 control chromosomes in the GnomAD database, including 579 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.018 ( 33 hom., cov: 32)
Exomes 𝑓: 0.026 ( 546 hom. )
Consequence
NSD1
ENST00000602285.1 non_coding_transcript_exon
ENST00000602285.1 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.11
Publications
2 publications found
Genes affected
NSD1 (HGNC:14234): (nuclear receptor binding SET domain protein 1) This gene encodes a protein containing a SET domain, 2 LXXLL motifs, 3 nuclear translocation signals (NLSs), 4 plant homeodomain (PHD) finger regions, and a proline-rich region. The encoded protein enhances androgen receptor (AR) transactivation, and this enhancement can be increased further in the presence of other androgen receptor associated coregulators. This protein may act as a nucleus-localized, basic transcriptional factor and also as a bifunctional transcriptional regulator. Mutations of this gene have been associated with Sotos syndrome and Weaver syndrome. One version of childhood acute myeloid leukemia is the result of a cryptic translocation with the breakpoints occurring within nuclear receptor-binding Su-var, enhancer of zeste, and trithorax domain protein 1 on chromosome 5 and nucleoporin, 98-kd on chromosome 11. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Sep 2018]
NSD1 Gene-Disease associations (from GenCC):
- Beckwith-Wiedemann syndrome due to NSD1 mutationInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Sotos syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen
- Sotos syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 5-177136078-A-G is Benign according to our data. Variant chr5-177136078-A-G is described in ClinVar as Benign. ClinVar VariationId is 261599.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0182 (2779/152284) while in subpopulation NFE AF = 0.0282 (1921/68020). AF 95% confidence interval is 0.0272. There are 33 homozygotes in GnomAd4. There are 1333 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 2779 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0183 AC: 2782AN: 152166Hom.: 33 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
2782
AN:
152166
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0213 AC: 4779AN: 224242 AF XY: 0.0222 show subpopulations
GnomAD2 exomes
AF:
AC:
4779
AN:
224242
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0259 AC: 33592AN: 1299036Hom.: 546 Cov.: 19 AF XY: 0.0261 AC XY: 17057AN XY: 653030 show subpopulations
GnomAD4 exome
AF:
AC:
33592
AN:
1299036
Hom.:
Cov.:
19
AF XY:
AC XY:
17057
AN XY:
653030
show subpopulations
African (AFR)
AF:
AC:
106
AN:
29378
American (AMR)
AF:
AC:
357
AN:
43546
Ashkenazi Jewish (ASJ)
AF:
AC:
358
AN:
25078
East Asian (EAS)
AF:
AC:
0
AN:
37664
South Asian (SAS)
AF:
AC:
2467
AN:
81000
European-Finnish (FIN)
AF:
AC:
1609
AN:
51718
Middle Eastern (MID)
AF:
AC:
184
AN:
5288
European-Non Finnish (NFE)
AF:
AC:
27342
AN:
970756
Other (OTH)
AF:
AC:
1169
AN:
54608
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1497
2994
4492
5989
7486
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
950
1900
2850
3800
4750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0182 AC: 2779AN: 152284Hom.: 33 Cov.: 32 AF XY: 0.0179 AC XY: 1333AN XY: 74460 show subpopulations
GnomAD4 genome
AF:
AC:
2779
AN:
152284
Hom.:
Cov.:
32
AF XY:
AC XY:
1333
AN XY:
74460
show subpopulations
African (AFR)
AF:
AC:
185
AN:
41566
American (AMR)
AF:
AC:
127
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
34
AN:
3472
East Asian (EAS)
AF:
AC:
3
AN:
5188
South Asian (SAS)
AF:
AC:
129
AN:
4826
European-Finnish (FIN)
AF:
AC:
319
AN:
10606
Middle Eastern (MID)
AF:
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1921
AN:
68020
Other (OTH)
AF:
AC:
27
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
139
278
418
557
696
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
53
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.